Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery

European Journal of Pharmaceutical Sciences

Volumn 47, Issue 2, 2012, Pages 430-443

  Chen, Jianian ^a,b   Li, Shaoshun ^a   Shen, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b GUANGXI NORMAL UNIVERSITY   (China)

Author keywords

Cell penetrating peptide; Folate; Nanoparticles; PLGA PEG; Vincristine sulfate

Indexed keywords

BIFUNCTIONAL NANOPARTICLE; FOLIC ACID; MACROGOL; NANOPARTICLE; POLY(LACTIC CO GLYCOLIC ACID)POLYETHYLENE GLYCOL; POLYGLACTIN; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CYTOTOXICITY; DRUG DELIVERY SYSTEM; EMULSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PARTICLE SIZE; PRIORITY JOURNAL; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; DRUG CARRIERS; FOLIC ACID; HUMANS; MCF-7 CELLS; NANOPARTICLES; OLIGOPEPTIDES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; VINCRISTINE;

EID: 84864414984     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.07.002     Document Type: Article

References (58)

1. H.L. Amand, K. Fant, B. Norden, and E.K. Esbjorner Stimulated endocytosis in penetration uptake: effect of arginine and lysine Biochem. Biophys. Res. Commun. 371 2008 621 625
2. S. Aroui, S. Brahim, M.D. Waard, and A. Kenani Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study Biochem. Biophys. Res. Commun. 391 2010 419 425
3. M. Barz, F. Canal, K. Koynov, R. Zentel, and M.J. Vicent Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake Biomacromolecules 11 2010 2274 2282
4. A.Y. Bedikian, J.A. Silverman, N.E. Papadopoulos, K.B. Kim, A.E. Hagey, A. Vardeleon, W.J. Hwu, J. Homsi, M. Davies, and P. Hwu Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function J. Clin. Pharmacol. 51 2011 1205 1212
5. S. Binet, E. Chaineau, A. Fellous, H. Lataste, A. Krikorian, J.P. Couzinier, and V. Meininger Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules Int. J. Cancer 46 1990 262 266
6. A. Chugh, F. Eudes, and Y.S. Shim Cell-penetrating peptides: nanocarrier for macromolecule delivery in living cells IUBMB Life 62 2010 183 193
7. E. Cohen-Sela, S. Teitlboim, M. Chorny, N. Koroukhov, H.D. Danenberg, J. Gao, and G. Golomb Single and double emulsion manufacturing techniques of an amphiphilic drug in PLGA nanoparticles: formulations of mithramycin and bioactivity J. Pharm. Sci. 98 2009 1452 1462
8. D. Cun, C. Foged, M. Yang, S. Frokjaer, and H.M. Nielsen Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery Int. J. Pharm. 390 2010 70 75
9. F. Danhier, E. Ansorena, J.M. Silva, R. Coco, A. Le Breton, and V. Préat PLGA-based nanoparticles: an overview of biomedical applications J. Controlled Release 2012 10.1016/j.jconrel.2012.01.043
10. J. Davda, and V. Labhasetwar Characterization of nanoparticle uptake by endothelial cells Int. J. Pharm. 233 2002 51 59
11. P. Desai, R.R. Patlolla, and M. Singh Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery Mol. Membr. Biol. 27 2010 247 259
12. A. El-Sayed, S. Futaki, and H. Harashima Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment AAPS J. 11 2009 13 22
13. F. Esmaeili, M.H. Ghahremani, S.N. Ostad, F. Atyabi, M. Seyedabadi, M.R. Malekshahi, M. Amini, and R. Dinarvand Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate J. Drug Target. 16 2008 415 423
14. S.B. Fonseca, M.P. Pereira, and S.O. Kelley Recent advances in the use of cell-penetrating peptides for medical and biological applications Adv. Drug Delivery Rev. 61 2009 953 964
15. C.W. Gan, and S.S. Feng Transferrin-conjugated nanoparticles of poly(lactide)-d-α-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier Biomaterials 31 2010 7748 7757
16. E. Goncalves, E. Kitas, and J. Seelig Binding of oligoarginine to membrane lipids and heparan sulfate: structural and thermodynamic characterization of a cell-penetrating peptide Biochemistry 44 2005 2692 2702
17. M.E. Herbig, K.M. Weller, and H.P. Merkle Reviewing biophysical and cell biological methodologies in cell-penetrating peptide (CPP) research Crit. Rev. Ther. Drug Carrier Syst. 24 2007 203 255
18. H.D. Herce, A.E. Garcia, J. Litt, R.S. Kane, P. Martin, N. Enrique, A. Rebolledo, and V. Milesi Arginine-rich peptides destabilize the plasma membrane, consistent with a pore formation translocation mechanism of cell-penetrating peptides Biophys. J. 97 2009 1917 1925
19. R.H. Himes, R.N. Kersey, I. Heller-Bettinger, and F.E. Samson Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro Cancer Res. 36 1976 3798 3802
20. K. Hu, J. Li, Y. Shen, W. Lu, X. Gao, Q. Zhang, and X. Jiang Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: in vitro and in vivo evaluations J. Controlled Release 134 2009 55 61
21. M.A. Jordan, D. Thrower, and L. Wilson Mechanism of inhibition of cell proliferation by Vinca alkaloids Cancer Res. 51 1991 2212 2222
22. L.A. Kassem, M.M. Gamal El-Din, and N.A. Yassin Mechanisms of vincristine-induced neurotoxicity: possible reversal by erythropoietin Drug Discovery Ther. 5 2011 136 143
23. J.R. Maiolo, M. Ferrer, and E.A. Ottinger Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides Biochim. Biophys. Acta 1712 2005 161 172
24. J. Marinina, A. Shenderova, S.R. Mallery, and S.P. Schwendeman Stabilization of vinca alkaloids encapsulated in poly(lactide-co-glycolide) microspheres Pharm. Res. 17 2000 677 683
25. C. Marty, C. Meylan, H. Schott, K. Ballmer-Hofer, and R.A. Schwendener Enhanced heparan sulfate proteoglycan-mediated uptake of cell-penetrating peptide-modified liposomes Cell. Mol. Life Sci. 61 2004 1785 1794
26. G. Mena-Rejon, E. Caamal-Fuentes, Z. Cantillo-Ciau, R. Cedillo-Rivera, J. Flores-Guido, and R. Moo-Puc In vitro cytotoxic activity of nine plants used in Mayan traditional medicine J. Ethnopharmacol. 121 2009 462 465
27. F.T. Meng, G.H. Ma, W. Qiu, and Z.G. Su W/O/W double emulsion technique using ethyl acetate as organic solvent: effects of its diffusion rate on the characteristics of microparticles J. Controlled Release 91 2003 407 416
28. M. Nahar, V. Dubey, D. Mishra, P.K. Mishra, A. Dube, and N.K. Jain In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis J. Drug Target. 18 2010 93 105
29. V.K. Ngan, K. Bellman, D. Panda, B.T. Hill, M.A. Jordan, and L. Wilson Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules Cancer Res. 60 2000 5045 5051
30. C.O. Noble, Z. Guo, M.E. Hayes, J.D. Marks, J.W. Park, C.C. Benz, D.B. Kirpotin, and D.C. Drummond Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine Cancer Chemother. Pharmacol. 64 2009 741 751
31. J. Pan, Y. Liu, and S.S. Feng Multifunctional nanoparticles of biodegradable copolymer blend for cancer diagnosis and treatment Nanomedicine 5 2010 347 360
32. S. Park, S. Kang, A.J. Veach, Y. Vedvyas, R. Zarnegar, J.Y. Kim, and M.M. Jin Self-assembled nanoplatform for targeted delivery of chemotherapy agents via affinity-regulated molecular interactions Biomaterials 31 2010 7766 7775
33. L.N. Patel, J.L. Zaro, and W.C. Shen Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives Pharm. Res. 24 2007 1977 1992
34. R.R. Patlolla, P.R. Desai, K. Belay, and M.S. Singh Translocation of cell penetrating peptide engrafted nanoparticles across skin layers Biomaterials 31 2010 5598 5607
35. J.P. Richard, K. Melikov, H. Brooks, P. Prevot, B. Lebleu, and L.V. Chernomordik Cellular uptake of unconjugated TAT peptide involves clathrin-dependent endocytosis and heparan sulfate receptors J. Biol. Chem. 280 2005 15300 15306
36. S.K. Sahoo, and V. Labhasetwar Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention Mol. Pharm. 2 2005 373 383
37. N. Schmidt, A. Mishra, G.H. Lai, and G.C. Wong Arginine-rich cell-penetrating peptides FEBS Lett. 584 2010 1806 1813
38. V.A. Sethuraman, M.C. Lee, and Y.H. Bae A biodegradable pH-sensitive micelle system for targeting acidic solid tumors Pharm. Res. 25 2008 657 666
39. M. Shimazawa, Y. Ito, Y. Inokuchi, and H. Hara Involvement of double-stranded RNA-dependent protein kinase in ER stress-induced retinal neuron damage Invest Ophthalmol. Vis. Sci. 48 2007 3729 3736
40. A. Skladanowski, M.G. Come, M. Sabisz, A.E. Escargueil, and A.K. Larsen Down-regulation of DNA topoisomerase IIα leads to prolonged cell cycle transit in G2 and early M phases and increased survival to microtubule- interacting agents Mol. Pharmacol. 68 2005 625 634
41. B. Stella, V. Marsaud, S. Arpicco, G. Geraud, L. Cattel, P. Couvreur, and J.M. Renoir Biological characterization of folic acid-conjugated poly(H2NPEGCA-co-HDCA) nanoparticles in cellular models J. Drug Target. 15 2007 146 153
42. Y. Su, A.J. Waring, P. Ruchala, and M. Hong Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR Biochemistry 49 2010 6009 6020
43. P.E. Thoren, D. Persson, P. Lincoln, and B. Norden Membrane destabilizing properties of cell-penetrating peptides Biophys. Chem. 114 2005 169 179
44. V.P. Torchilin Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery Biopolymers 90 2008 604 610
45. Y.L. Tseng, J.J. Liu, and R.L. Hong Translocation of liposomes into cancer cells by cell-penetrating peptides penetration and tat: a kinetic and efficacy study Mol. Pharmacol. 62 2002 864 872
46. L.E. van Vlerken, T.K. Vyas, and M.M. Amiji Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery Pharm. Res. 24 2007 1405 1414
47. M. Wang, and M. Thanou Targeting nanoparticles to cancer Pharmacol. Res. 62 2010 90 99
48. Z. Wang, W.-K. Chui, and P. Ho Design of a multifunctional PLGA nanoparticulate drug delivery system: evaluation of its physicochemical properties and anticancer activity to malignant cancer cells Pharm. Res. 26 2009 1162 1171
49. J.F. Wang, W.M. Liu, Q. Tu, J.C. Wang, N. Song, Y.R. Zhang, N. Nie, and J.Y. Wang Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery Biomacromolecules 228 2011 228 234
50. S.P. Wang, T.K. Chen, R. Chen, Y.Y. Hu, M.W. Chen, and Y.T. Wang Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies Int. J. Pharm. 430 2012 238 246
51. K.Y. Win, and S.S. Feng Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs Biomaterials 26 2005 2713 2722
52. L. Wu, C. Tang, and C. Yin Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol) Drug Dev. Ind. Pharm. 36 2010 439 448
53. S.J. Yang, F.H. Lin, K.C. Tsai, M.F. Wei, H.M. Tsai, J.M. Wong, and M.J. Shieh Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells Bioconjugate Chem. 21 2010 679 689
54. X. Yang, J.J. Grailer, I.J. Rowland, A. Javadi, S.A. Hurley, D.A. Steeber, and S. Gong Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging Biomaterials 31 2010 9065 9073
55. H.S. Yoo, and T.G. Park Folate receptor targeted biodegradable polymeric doxorubicin micelles J. Controlled Release 96 2004 273 283
56. P. Zhang, L. Hu, Y. Wang, J. Wang, L. Feng, and Y. Li Poly(-caprolactone)-block-poly(ethylethylene phosphate) micelles for brain-targeting drug delivery: in vitro and in vivo valuation Pharm. Res. 27 2010 2657 2669
57. G. Zhu, S.R. Mallery, and S.P. Schwendeman Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) Nat. Biotechnol. 18 2000 52 57
58. A. Ziegler, X.L. Blatter, A. Seelig, and J. Seelig Protein transduction domains of HIV-1 and SIV TAT interact with charged lipid vesicles. Binding mechanism and thermodynamic analysis Biochemistry 42 2003 9185 9194